Dear Editor,

In the context of an update of the Dutch guideline on non-small-cell lung cancer, we performed a systematic review on the clinical effectiveness of low-dose (i.e. \<30 Gy) *versus* high-dose palliative radiotherapy (i.e. ≥30 Gy). We identified the recent meta-analysis of Ma *et al*.[@b1] that included five randomized trials published until June 2013. Our systematic review confirmed the completeness of the search of Ma *et al*. However, when we examined the forest plot of the effect on 1-year overall survival, the Dutch trial of Kramer *et al*.[@b2] was found to be discordant with the four other included studies. Verification of the full-text publication confirmed that Kramer\'s results were wrongly extracted by Ma *et al*. (high-dose, 11% instead of 20%; low-dose, 20% instead of 11%), possibly resulting in an underestimation of the pooled effect and wrong conclusions. We would like to ask the authors to redo the meta-analysis with the correct data, and to reconsider the conclusions based on the new results.
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